BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 24148073)

  • 1. Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma.
    Negishi Y; Sakai K; Noguchi Y; Iwasaki N; Kawai N
    J Obstet Gynaecol Res; 2014 Feb; 40(2):614-7. PubMed ID: 24148073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
    Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
    J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.
    Kumari VA; Gupta P; Srivastava MV; Kumar L; Kriplani A; Bhatla N
    J Obstet Gynaecol Res; 2014 May; 40(5):1463-5. PubMed ID: 24689522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer and late onset paraneoplastic cerebellar degeneration.
    Goldstein BH; Birk CL; Van Houten M; Veve R; Brown JV; Rettenmaier MA; Micha JP
    Arch Gynecol Obstet; 2009 Jul; 280(1):99-101. PubMed ID: 18987868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated ZIC4 antibodies in paraneoplastic cerebellar syndrome with an underlying ovarian tumor.
    Kerasnoudis A; Rockhoff M; Federlein J; Gold R; Krogias C
    Arch Neurol; 2011 Aug; 68(8):1073. PubMed ID: 21825246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.
    Saeed DB; Gupta L
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic cerebellar degeneration: neurological symptoms pointing to occult ovarian cancer.
    Geomini PM; Dellemijn PL; Bremer GL
    Gynecol Obstet Invest; 2001; 52(2):145-6. PubMed ID: 11586046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paraneoplastic neurologic degeneration revealing ovarian cancer recurrence].
    Zouiten O; Benbrahim Z; Amaadour L; Mellas N
    Pan Afr Med J; 2019; 33():281. PubMed ID: 31692829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic cerebellar degeneration as the first manifestation of cancer.
    Lin JT; Lachmann E; Nagler W
    J Womens Health Gend Based Med; 2001 Jun; 10(5):495-502. PubMed ID: 11445049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
    Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
    Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration.
    Forgy AP; Ewing TL; Flaningam J
    Gynecol Oncol; 2001 Jan; 80(1):96-8. PubMed ID: 11136578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration.
    Finsterer J; Voigtländer T; Grisold W
    J Neurol Sci; 2011 Sep; 308(1-2):139-41. PubMed ID: 21762925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic cerebellar degeneration in a woman with ovarian cancer.
    Santillan A; Bristow RE
    Nat Clin Pract Oncol; 2006 Feb; 3(2):108-12; quiz 1 p following 112. PubMed ID: 16462852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma.
    Tanaka Y; Suzuki N; Takao M; Ichikawa A; Susumu N; Aoki D
    Gynecol Oncol; 2005 Nov; 99(2):500-3. PubMed ID: 16126258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic cerebellar degeneration as the first evidence of cancer: a case report.
    Liu S; Tunkel R; Lachmann E; Nagler W
    Arch Phys Med Rehabil; 2000 Jun; 81(6):834-6. PubMed ID: 10857534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
    Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paraneoplastic cerebellar degeneration. A case report].
    Storstein A; Vedeler C; Krossnes B; Mørk S
    Tidsskr Nor Laegeforen; 1997 Aug; 117(20):2947-8. PubMed ID: 9340852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.